Shares of Inspire Medical Systems INSP were flat in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share were down 175.00% year over year to ($0.88), which beat the estimate of ($1.10).
Revenue of $12,183,000 declined by 32.44% from the same period last year, which beat the estimate of $7,850,000.
Outlook
Earnings guidance hasn't been issued by the company for now.
Revenue guidance hasn't been issued by the company for now.
How To Listen To The Conference Call
Date: Aug 04, 2020
Time: 05:00 PM
ET Webcast URL: http://public.viavid.com/player/index.php?id=140429
Price Action
Company's 52-week high was at $105.53
Company's 52-week low was at $40.53
Price action over last quarter: Up 46.22%
Company Overview
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.